Lab21 Among First to Offer FDA Approved Companion Diagnostic in the US

News   Jul 16, 2012

 
Lab21 Among First to Offer FDA Approved Companion Diagnostic in the US
 
 
 

RELATED ARTICLES

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

WGS Identifies New Genetic Signature for Autism

News

An analysis of the complete genomes of 2,064 people reveals that multiple genetic variations could contribute to autism.

READ MORE

Scientists Reveal the Relationship Between Sugar and Cancer

News

By analysisng metabolites scientists have clarified how the Warburg effect, a phenomenon in which cancer cells rapidly break down sugars, stimulates tumor growth.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE